Mynvax

Bangalore, India · Founded 2017 · Privately Held (backing)

Developer of novel drugs designed to be used in vaccines for respiratory viruses. Mynvax is based in Bangalore, India and was founded in 2017. Its last known valuation is $29.8 million. It has raised $12.7 million.

Last price · $/share

—

Implied valuation

$29.8M

Total raised

$12.7M

Last round

—

How much has Mynvax raised?

$12.7Macross 0 recorded rounds

Free account

More of Mynvax with a free account

·The complete investor list: 15 names
·Watch Mynvax: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Mynvax investors

15 investors are on record for Mynvax, including Accel, LetsVenture Technologies, Accel India and Legacy Assets.

For fundraisers

Raising for a company like Mynvax?

15 investors have backed Mynvax.

See all 15 investors →

Frequently asked about Mynvax

How much has Mynvax raised?: Mynvax has raised $12.7M in total across 0 recorded funding rounds.